UBS Maintains Neutral on Bath & Body Works, Lowers Price Target to $19

Benzinga Newsdesk www.benzinga.com Negative 85.6%

Neg 85.6% Neu 0% Pos 0%

UBS analyst Jay Sole maintains Bath & Body Works (NYSE:BBWI) with a Neutral and lowers the price target from $22 to $19.